5% stakes
Logos Global Management
Institution
- 5% stake reports
- 26
- 5% stake stocks
- 15
- Latest report
- 26/09/10
5% stake reports
| Stock | ||
|---|---|---|
| Longeveron LGVN09/10 | 6.3%192,308 sh | First report |
| Achieve Life Sciences ACHV08/17 | 9.99%10,538,440 sh | First report |
| Yarrow Bioscience YARW08/04 | 9.9%276,704 sh | First report |
| Tenax Therapeutics TENX05/15 | 3%800,000 sh | −6.9pp |
| iBio05/15 | 0%0 sh | −4.6pp |
| Avalo Therapeutics AVTX05/15 | 3.2%1,675,000 sh | −2.4pp |
| Avalo Therapeutics AVTX04/01 | 5.6%1,285,000 sh | First report |
| Tenax Therapeutics TENX03/09 | 9.9%615,000 sh | First report |
| iBio02/17 | 4.6%1,500,000 sh | −4.3pp |
| Minerva Neurosciences NERV02/17 | 9.9%4,435,444 sh | First report |
| iBio25/12/19 | 8.9%2,000,000 sh | First report |
| Design Therapeutics DSGN25/11/18 | 4.4%2,515,000 sh | −1.3pp |
| Palatin Technologies PTN25/11/14 | 9.9%142,292 sh | First report |
| Verastem VSTM25/11/14 | 4.8%3,175,000 sh | −1.4pp |
| Erasca ERAS25/11/14 | 4.8%13,600,000 sh | −0.5pp |
| Design Therapeutics DSGN25/11/12 | 5.7%3,255,000 sh | No earlier report |
| Arvinas ARVN25/10/15 | 3.4%2,500,000 sh | −5.2pp |
| Arvinas ARVN25/08/22 | 8.6%6,300,000 sh | +2.2pp |
| Erasca ERAS25/08/14 | 5.3%15,100,000 sh | First report |
| Prothena Corp Public PRTA25/08/14 | 0%0 sh | −5.5pp |
